Organization · Venture Capital
P74 Ventures
P74 Ventures is a Boston-based venture capital firm focused on the intersection of pharmaceuticals and technology, investing in early-stage companies that enhance healthcare access and improve global health.
Overview
What P74 Ventures does
What P74 Ventures is
P74 Ventures is a Boston-based venture capital firm focused on the intersection of pharmaceuticals and technology, investing in early-stage companies that enhance healthcare access and improve global health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find P74 Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
P74 Ventures as a funder
Investment thesis
P74 Ventures focuses on enabling technologies that address pharma's business bottlenecks, including drug cost, patient access, and supply-chain performance. They invest in early-stage companies where at least one pharmaceutical company can be a founding partner or collaborator.
Focus narrative
P74 Ventures invests in early-stage pharma-tech and platform-technology companies that can transform the operations of pharmaceutical businesses. Their focus is on initiatives that enhance healthcare access and improve global health outcomes.
Value beyond capital
P74 Ventures provides strategic support to portfolio companies by leveraging deep industry experience and connections within the pharmaceutical sector, facilitating partnerships and collaborations that enhance business growth.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B · Growth Equity
- Regions
- North America · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
TransVoyant: An intelligent supply-chain execution platform, co-led by P74 Ventures in a strategic growth equity financing round with Merck Global Health Innovation Fund in December 2022.
Common questions
What to know about P74 Ventures
Upseed classifies P74 Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.